Publication | Open Access
The burden of illness of patients with paroxysmal nocturnal haemoglobinuria receiving <scp>C5</scp> inhibitors in France, Germany and the United Kingdom: Patient‐reported insights on symptoms and quality of life
33
Citations
30
References
2022
Year
Results suggest that there remains a considerable burden and unmet need among C5i-treated patients with PNH that requires improved therapies.
| Year | Citations | |
|---|---|---|
Page 1
Page 1